288 related articles for article (PubMed ID: 34903600)
1. Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype.
Nishida-Aoki N; Gujral TS
Cancer Res; 2022 Feb; 82(3):433-446. PubMed ID: 34903600
[TBL] [Abstract][Full Text] [Related]
2. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
3. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
Liu H; Yao M; Ren J
Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.
Hey J; Halperin C; Hartmann M; Mayer S; Schönung M; Lipka DB; Scherz-Shouval R; Plass C
Int J Cancer; 2023 Mar; 152(6):1226-1242. PubMed ID: 36408934
[TBL] [Abstract][Full Text] [Related]
5. Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs.
Shao S; Miao H; Ma W
Front Immunol; 2023; 14():1295684. PubMed ID: 38035068
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
7. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling.
Lee SG; Woo SM; Seo SU; Lee CH; Baek MC; Jang SH; Park ZY; Yook S; Nam JO; Kwon TK
Exp Mol Med; 2024 Feb; 56(2):383-394. PubMed ID: 38297161
[TBL] [Abstract][Full Text] [Related]
9. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
Li L; Tian Y
Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
[TBL] [Abstract][Full Text] [Related]
10. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
12. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
13. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
[TBL] [Abstract][Full Text] [Related]
14. Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment.
Wang L; Zhao L; Gong FL; Sun C; Du DD; Yang XX; Guo XL
Acta Pharmacol Sin; 2022 Jun; 43(6):1556-1567. PubMed ID: 34462562
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
16. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
17. Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
Tigue ML; Loberg MA; Goettel JA; Weiss WA; Lee E; Weiss VL
Cancer Res; 2023 Jan; 83(1):3-11. PubMed ID: 36214645
[TBL] [Abstract][Full Text] [Related]
18. Macrophage targeting in cancer.
Lopez-Yrigoyen M; Cassetta L; Pollard JW
Ann N Y Acad Sci; 2021 Sep; 1499(1):18-41. PubMed ID: 32445205
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
20. Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases.
Soldani C; De Simone G; Polidoro MA; Morabito A; Franceschini B; Colombo FS; Anselmo A; Milana F; Lleo A; Torzilli G; Pastorelli R; Donadon M; Brunelli L
Cancer Immunol Immunother; 2024 Mar; 73(4):63. PubMed ID: 38430255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]